Double stimulation for the management of poor-prognosis patients: where are we going?

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
Pasquale Petrone, Alberto Vaiarelli, Christophe Blockeel
{"title":"Double stimulation for the management of poor-prognosis patients: where are we going?","authors":"Pasquale Petrone,&nbsp;Alberto Vaiarelli,&nbsp;Christophe Blockeel","doi":"10.1097/GCO.0000000000000869","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>The technical improvements in IVF allowed the implementation of nonconventional ovarian stimulation protocols for some specific patients. Where time is crucial, such as with oncologic patients, poor-prognosis patients, patients with low ovarian reserve, and those with advanced maternal age, access to IVF treatment is even more critical. Some of these protocols might start in the late follicular phase, luteal phase, or involve both stimulations within the same ovarian cycle.</p><p><strong>Recent findings: </strong>Until now, published evidence showed that oocytes retrieved from unconventional protocol seem to be developmentally, genetically, and reproductively competent. Second stimulation in the same ovarian cycle after the conventional approach may represent a sound alternative to oocyte accumulation. This can be proposed in progress after careful counselling focused on the patients' chances of finding at least one euploid embryo on account of their age and of the number of blastocysts obtained after the conventional approach.</p><p><strong>Summary: </strong>The adoption of these new strategies, known as double stimulation protocol, can be conceived as a real full-personalization of ovarian stimulation. Multicentre prospective RCTs are urgently needed to evaluate the efficacy, efficiency, and costs of double stimulation versus two consecutive conventional approaches with standard or mild stimulation and in a different IVF setting.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/GCO.0000000000000869","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose of review: The technical improvements in IVF allowed the implementation of nonconventional ovarian stimulation protocols for some specific patients. Where time is crucial, such as with oncologic patients, poor-prognosis patients, patients with low ovarian reserve, and those with advanced maternal age, access to IVF treatment is even more critical. Some of these protocols might start in the late follicular phase, luteal phase, or involve both stimulations within the same ovarian cycle.

Recent findings: Until now, published evidence showed that oocytes retrieved from unconventional protocol seem to be developmentally, genetically, and reproductively competent. Second stimulation in the same ovarian cycle after the conventional approach may represent a sound alternative to oocyte accumulation. This can be proposed in progress after careful counselling focused on the patients' chances of finding at least one euploid embryo on account of their age and of the number of blastocysts obtained after the conventional approach.

Summary: The adoption of these new strategies, known as double stimulation protocol, can be conceived as a real full-personalization of ovarian stimulation. Multicentre prospective RCTs are urgently needed to evaluate the efficacy, efficiency, and costs of double stimulation versus two consecutive conventional approaches with standard or mild stimulation and in a different IVF setting.

双重刺激对不良预后患者的管理:我们将走向何方?
综述目的:体外受精技术的进步使一些特殊患者能够实施非常规卵巢刺激方案。在时间至关重要的情况下,如肿瘤患者、预后不良患者、卵巢储备功能低下患者和高龄产妇,获得体外受精治疗就更为关键。其中一些方案可能在卵泡晚期、黄体期开始,或在同一卵巢周期内同时进行两种刺激。最新发现:到目前为止,已发表的证据表明,从非常规方案中提取的卵母细胞似乎在发育、遗传和生殖方面都具有能力。在常规方法后,在同一卵巢周期内进行第二次刺激可能是卵母细胞积累的一种良好替代方法。考虑到患者的年龄和传统方法获得的囊胚数量,在仔细咨询患者发现至少一个整倍体胚胎的机会后,可以提出这一建议。摘要:采用这些新策略,被称为双重刺激方案,可以被认为是一个真正的完全个性化的卵巢刺激。迫切需要多中心前瞻性随机对照试验来评估双重刺激与标准或轻度刺激和不同试管婴儿环境下连续两种常规方法的疗效、效率和成本。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信